The mission of the National Institute of Allergy and Infectious Diseases (NIAID) is to conduct and support research to better understand, diagnose, treat, and ultimately prevent infectious, immunologic, and allergic diseases. NIAID supports research ranging from studies of the fundamental mechanisms of infectious and immunological diseases to more applied studies aimed at developing and testing new diagnostics, therapeutics, and vaccines.
This edition of the NIAID Year in Review highlights the Institute’s programmatic and scientific accomplishments during Fiscal Year 2011 and describes how our budget is distributed by research programs and funding mechanisms. In addition, this Year in Review celebrates the successes of NIAID-funded investigators. During FY 2011, three researchers received the Nobel Prize in Physiology or Medicine for discovering some of the earliest events in the initiation of an immune response—work that was supported in part by NIAID.
The 2011 NIAID Year in Review focuses on a highly productive year at NIAID. Through the basic and clinical research that NIAID conducts and supports, the Institute will continue to advance the development of vaccines, therapeutics, and diagnostics to improve health and save millions of lives throughout the world.
Anthony S. Fauci, M.D.DirectorNational Institute of Allergy and Infectious DiseasesNational Institutes of Health
Last Updated February 12, 2013